Guiding effect of lactic acid clearance rate detection after early goal-directed therapy on timing selection of continuous blood purification for septic shock in children

doi:10.3877/cma.j.issn.1673-5250.2020.05.007

Objective

To explore guiding effect of lactic acid clearance rate detection of children with septic shock (SS) after receiving early goal-directed therapy (EGDT) on timing selection of further receiving continuous blood purification (CBP).

Methods

From January 2017 to December 2019, a total of 36 children with SS admitted to pediatric intensive care unit (PICU) in Maternity and Child Health Care Hospital of Guangxi Zhuang Autonomous Region were selected as research subjects, with lactic acid clearance rate<10% after receiving EGDT and meeting the inclusion and exclusion criteria of this study. The children with SS were randomly divided into study group (n=21) and control group (n=15) by envelope method. They were treated with early CBP, or first treated with cluster therapy, and then treated with CBP if their organ functions showed progressive deterioration, respectively. General clinical data, plasma levels of interleukin (IL)-6, 10 and tumor necrosis factor (TNF)-α on admission (d0), 3 days after admission (d3), and 5 days after admission (d5), and duration of plasma lactic acid concentration up to standard level, duration of urine volume up to standard level, CBP treatment time, mechanical ventilation time, and hospital stay in PICU of two groups were collected. ANOVA of repeated measurement data and independent-samples t test were used for statistical comparisons. There were no statistical differences between two groups in general clinical data, such as composition ratios of gender, age and primary infection locations, plasma lactic acid concentration before treatment, and pediatric critical illness score (PCIS) (P>0.05). The procedure followed in this study conformed to the standards of medical ethics in Maternity and Child Health Care Hospital of Guangxi Zhuang Autonomous Region and has been approved by this ethics committee [approval No. (2017-1)4-16]. All guardians of children have signed informed consent of clinical research.

Results

①ANOVA of repeated measurement data results of plasma IL-6, IL-10 and TNF-α levels on d0, d3 and d3 showed that as for plasma levels of IL-6 and IL-10, the interaction between different treatment measures and time factors was statistically significant (F_{treatment×time}=14.937, P<0.001; F_{treatment×time}=5.314, P<0.001), while as for plasma level of TNF-α, the interaction between different treatment measures and time factors was not statistically significant (F_{treatment×time}=2.918, P=0.092). Results of further analysis by fixing time factor showed that plasma levels of IL-6, IL-10 and TNF-α on d3 in study group were significantly lower than those in control group, and all differences were statistically significant (t=-4.957, P<0.001; t=-6.545, P<0.001; t=-2.638, P=0.012). Results of further analysis by fixing factor of treatment measures showed that plasma levels of IL-6, IL-10 and TNF-α in study group and control group showed a progressive decrease trend, and there were statistical differences in further comparisons between different times within each group (P<0.05) except for the comparison of d3 and d5 plasma levels of TNF-α in study group. ②Duration of plasma lactic acid concentration up to standard level, duration of urine volume up to standard level, CBP treatment time, mechanical ventilation time, and hospital stay in PICU of children in study group were (4.7±1.2) d, (4.3±1.5) d, (3.4±1.2) d, (7.1±1.7) d, (10.1±2.4) d, respectively, which were significantly shorter than those in control group (6.3±1.4) d, (5.4±1.3) d, (4.3±1.1) d, (8.4±1.8) d, (12.8±2.5) d, and all differences were statistically significant (t=3.648, 2.192, 2.397, 2.173, 3.294, P=0.001, 0.035, 0.022, 0.037, 0.002).

Conclusions

Early CBP treatment for SS children with lactic acid clearance rate<10% after receiving EGDT can rapidly reduce intensity of inflammatory response, control the disease, and shorten course of disease. Due to relatively small sample size included in this study, guiding effect of lactic acid clearance rate after receiving EGDT on timing selection of CBP for children with SS still needs to be further confirmed by multi-center, large-sample, randomized controlled trials.

Key words: Shock, septic, Hemodiafiltration, Lactic acid, Interleukin-6, Interleukin-10, Tumor necrosis factor-alpha, Early goal-directed therapy, Lactic acid clearance rate, Continuous blood purification, Child

表1 2组脓毒性休克患儿临床资料比较

组别	例数	性别[例数(%)]		年龄[例数(%)]			治疗前血浆乳酸浓度(mmol/L，±s)
组别	例数	男	女	<1岁	1～3岁	>3岁	治疗前血浆乳酸浓度(mmol/L，±s)
研究组	21	12(57.1)	9(42.9)	9(42.9)	6(28.6)	6(28.6)	5.4±1.6
对照组	15	8(53.3)	7(46.7)	7(46.7)	5(33.3)	3(20.0)	5.1±2.1
检验值		χ²＝0.051		χ²＝0.351			t＝0.488
P值		0.821		0.839			0.629
组别	例数	原发感染部位[例数(%)]					治疗前PCIS(分，±s)
组别	例数	肺部	肠道及腹腔	血流	中枢神经系统	其他部位	治疗前PCIS(分，±s)
研究组	21	6(28.6)	5(23.8)	5(23.8)	2(9.5)	3(14.3)	66.4±7.2
对照组	15	5(33.3)	3(20.0)	4(26.7)	2(13.3)	1(6.7)	69.5±7.3
检验值		χ²＝0.722					t＝-1.278
P值		0.949					0.210

表1 2组脓毒性休克患儿临床资料比较

组别	例数	性别[例数(%)]		年龄[例数(%)]			治疗前血浆乳酸浓度(mmol/L，±s)
组别	例数	男	女	<1岁	1～3岁	>3岁	治疗前血浆乳酸浓度(mmol/L，±s)
研究组	21	12(57.1)	9(42.9)	9(42.9)	6(28.6)	6(28.6)	5.4±1.6
对照组	15	8(53.3)	7(46.7)	7(46.7)	5(33.3)	3(20.0)	5.1±2.1
检验值		χ²＝0.051		χ²＝0.351			t＝0.488
P值		0.821		0.839			0.629
组别	例数	原发感染部位[例数(%)]					治疗前PCIS(分，±s)
组别	例数	肺部	肠道及腹腔	血流	中枢神经系统	其他部位	治疗前PCIS(分，±s)
研究组	21	6(28.6)	5(23.8)	5(23.8)	2(9.5)	3(14.3)	66.4±7.2
对照组	15	5(33.3)	3(20.0)	4(26.7)	2(13.3)	1(6.7)	69.5±7.3
检验值		χ²＝0.722					t＝-1.278
P值		0.949					0.210

表2 2组脓毒性休克患儿不同时间炎症指标比较(pg/mL，±s)

组别	例数	血浆IL-6水平			血浆IL-10水平			血浆TNF-α水平
组别	例数	d0	d3	d5	d0	d3	d5	d0	d3	d5
研究组	21	425±141	134±56	69±27	151±58	25±11	17±8	54±17	16±7	16±9
对照组	15	412±165	284±107	83±44	140±54	54±15	19±11	60±22	24±11	15±8
F_{处理×时间}值		14.937			5.314			2.918
P值		<0.001			0.027			0.092
F_处理值		3.042			0.571			1.294
P值		0.090			0.454			0.264
F_时间值		232.365			233.391			283.812
P值		<0.001			<0.001			<0.001

表2 2组脓毒性休克患儿不同时间炎症指标比较(pg/mL，±s)

组别	例数	血浆IL-6水平			血浆IL-10水平			血浆TNF-α水平
组别	例数	d0	d3	d5	d0	d3	d5	d0	d3	d5
研究组	21	425±141	134±56	69±27	151±58	25±11	17±8	54±17	16±7	16±9
对照组	15	412±165	284±107	83±44	140±54	54±15	19±11	60±22	24±11	15±8
F_{处理×时间}值		14.937			5.314			2.918
P值		<0.001			0.027			0.092
F_处理值		3.042			0.571			1.294
P值		0.090			0.454			0.264
F_时间值		232.365			233.391			283.812
P值		<0.001			<0.001			<0.001

表3 2组脓毒性休克患儿预后相关指标比较(d，±s)

组别	例数	血浆乳酸浓度达标时间	尿量达标时间	CBP治疗时间	机械通气时间	PICU住院时间
研究组	21	4.7±1.2	4.3±1.5	3.4±1.2	7.1±1.7	10.1±2.4
对照组	15	6.3±1.4	5.4±1.3	4.3±1.1	8.4±1.8	12.8±2.5
t值		3.648	2.192	2.397	2.173	3.294
P值		0.001	0.035	0.022	0.037	0.002

表3 2组脓毒性休克患儿预后相关指标比较(d，±s)

组别	例数	血浆乳酸浓度达标时间	尿量达标时间	CBP治疗时间	机械通气时间	PICU住院时间
研究组	21	4.7±1.2	4.3±1.5	3.4±1.2	7.1±1.7	10.1±2.4
对照组	15	6.3±1.4	5.4±1.3	4.3±1.1	8.4±1.8	12.8±2.5
t值		3.648	2.192	2.397	2.173	3.294
P值		0.001	0.035	0.022	0.037	0.002

[1]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287.
[2]	Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008, 36(1): 296-327. DOI: 10.1007/s00134-007-0934-2.
[3]	李雷雷，龚海蓉，王莹，等. 严重脓毒症患儿连续血液净化治疗多中心前瞻性研究[J]. 中华儿科杂志，2014, 52(6): 438-443. DOI: 10.3760/cmaj.issn.0578-1310.2014.06.009.
[4]	Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial[J]. JAMA, 2016, 315(20): 2190-2199. DOI: 10.1001/jama.2016.5828.
[5]	Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal replacement therapy in the intensive care unit[J]. N Engl J Med, 2016, 375(2): 122-133. DOI: 10.1056/NEJMoa1603017.
[6]	Gutierrez G, Wulf ME. Lactic acidosis in sepsis: another commentary[J]. Crit Care Med, 2005, 33(10): 2420-2422. DOI: 10.1097/01.ccm.0000183003.65144.c7.
[7]	Martin J, Blobner M, Busch R, et al. Point-of-care testing on admission to the intensive care unit: lactate and glucose independently predict mortality[J]. Clin Chem Lab Med, 2013, 51(2): 405-412. DOI: 10.1515/cclm-2012-0258.
[8]	江乐，应利君，吕铁. 乳酸清除率对感染性创面导致脓毒性休克患者疗效与生存状况的评估价值[J]. 中华医院感染学杂志，2017, 27(9): 1959-1962. DOI: 10.11816/cn.ni.2017-163248.
[9]	袁文浩，曾凌空，蔡保欢，等. 动脉血乳酸对于新生儿休克严重程度和预后判断的价值[J]. 中国当代儿科杂志，2018, 20(1): 17-20. DOI: 10.7499/j.issn.1008-8830.2018.01.004.
[10]	中华医学会儿科学分会急救学组，中华医学会急诊医学分会儿科学组，中国医师协会儿童重症医师分会. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志，2015, 53(8): 576-580. DOI: 10.3760/cma.j.issn.1673-4912.2015.11.001.
[11]	Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update[J]. Intensive Care Med, 2018, 44(6): 925-928. DOI: 10.1007/s00134-018-5085-0.
[12]	Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of sepsis shock and sepsis-associated organ dysfunction in children[J]. Pediatr Crit Care Med, 2020, 21(2): e52-e106. DOI: 10.1097/PCC.0000000000002198.
[13]	van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17(7): 407-420. DOI: 10.1038/nri.2017.36.
[14]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. DOI: 10.1007/s00134-017-4683-6.
[15]	Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for sepcic shock[J]. N Engl J Med, 2015, 372(14): 1301-1311. DOI: 10.1056/NEJMoa1500896.
[16]	PRISM Investgators, Rowan KM, Angus DC, et al. Early, goal-directed therapy for septic shock: a patient-level Meta-analysis[J]. N Engl J Med, 2017, 376(23): 2223-2234. DOI: 10.1056/NEJMoa1701380.
[17]	尚秀玲，刘大为，王小亭，等. 感染性休克患者早期目标导向治疗后动脉血乳酸清除率与预后及心肌损伤的关系[J]. 中华内科杂志，2018, 57(5): 345-350. DOI: 10.3760/cma.j.issn.0578-1426.2018.05.008.
[18]	Englert JA, Rogers AJ. Metabolism, metabolomics, and nutritional support of patients with sepsis[J]. Clin Chest Med, 2016, 37(2): 321-331. DOI: 10.1016/j.ccm.2016.01.011.
[19]	Jiwaji Z, Brady S, McIntyre LA, et al. Emergency department management of early sepsis: a national survey of emergency medicine and intensive care consultants[J]. Emerg Mad J, 2014, 31(12): 1000-1005. DOI: 10.1136/emermed-2013-202883.
[20]	Arnold RC, Shapiro NI, Jones AE, et al. Muhicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis[J]. Shock, 2009, 32(1): 35-39. DOI: 10.1097/shk.0b013e3181971d47
[21]	Vanni S, Viviani G, Baioni M，et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thromboembolism lactate outcome study[J]. Ann Emerg Med, 2013, 61(3): 330-338. DOI: 10.1016/j.annemergmed.2012.10.022
[22]	刘晓原，裴源源，朱继红. 脓毒性休克致急性肾损伤患者的危险因素分析[J/CD]. 中华危重症医学杂志(电子版), 2018, 11(6): 366-371. DOI: 10.3877/cma.j.issn.1674-6880.2018.06.002.
[23]	谢友军，莫武桂，韦跃，等. 早期连续血液净化治疗对儿童脓毒性休克预后的影响：前瞻性随机对照研究[J]. 中国当代儿科杂志，2020, 22(6): 573-577. DOI: 10.7499/j.issn.1008-8830.2002128.
[24]	Kogelmann K, Jarczak D, Scheller M, et al. Hemoadsorption by CytoSorb in septic patients: a case series[J]. Crit Care, 2017, 21(1): 74. DOI: 10.1186/s13054-017-1662-9.
[25]	孟婷，周巧玲. 感染性休克的血液净化治疗[J]. 临床内科杂志，2015, 32(6): 374-376. DOI: 10.3969/j.issn.1001-9057.2015.06.004.
[26]	Alobaidi R, Basu RK, Goldstein SL, et al. Sepsis-associated acute kidney injury[J]. Semin Nephrol, 2015, 35(1): 2-11. DOI: 10.1016/j.semnephrol.2015.01.002.
[27]	Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis[J]. N Engl J Med, 2018, 379(15): 1431-1442. DOI: 10.1056/NEJMoa1803213.
[28]	Pool R, Gomez H, Kellum JA. Mechanisms of organ dysfunction in sepsis[J]. Crit Care Clin, 2018, 34(1): 63-80. DOI: 10.1016/j.ccc.2017.08.003.
[29]	Russell JA, Rush B, Boyd J. Pathophysiology of septic shock[J]. Crit Care Clin, 2018, 34(1): 43-61. DOI: 10.1016/j.ccc.2017.08.005.
[30]	Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management[J]. BMJ, 2016, 353: i1585. DOI: 10.1136/bmj.i1585.

[1]	Hongyu Tao, Jingjing Ye, Jin Yu, Xiuzhen Yang, Jingjing Qian, Bin Xu, Weize Xu, Qiang Shu. Value of contrast transthoracic echocardiography in assessing right-to-left shunt-related diseases in children[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(10): 959-965.
[2]	Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[3]	Qin Liu, Hanmin Liu, Liang Xie. Current status of research on the role of matrix metalloproteinases in the pathogenesis of childhood asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 564-568.
[4]	Yun Xiang, You Lu, Fan Yang. Current research status of correlation between per-and polyfluoroalkyl substances exposure and childhood obesity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 569-574.
[5]	Yuxiao Zhang, Fan Yang, Meng Mao. Interpretation of Catch-Up Growth in Infants and Young Children with Faltering Growth：Expert Opinion to Guide General Clinicians[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 361-366.
[6]	Xiaoli Yang, Wanfu Li, Zhu Ma, Lan Ma, Yi Zheng, Xiaoli Fu, Jing Wang. Application effect of one-step forceps needle method in laparoscopic high ligation of hernia sac in children[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 535-538.
[7]	Hebei Ding, Xun Wang, Weiguo Chen. Comparison of application of sevoflurane inhalation anesthesia and propofol intravenous anesthesia in pediatric indirect inguinal hernia surgery[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 570-574.
[8]	Chinese Society of Organ Transplantation of Chinese Medical Association, Surgery Group of Chinese Society of Surgery of Chinese Medical Association, Transplantation Group of Chinese Society of Surgery of Chinese Medical Association, South China Alliance of Split Liver Transplantation. Chinese Clinical Practice Guidelines on Split Liver Transplantation in Children[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 593-601.
[9]	Jun Liu, Wenjing Qiu, Fanghao Sun, Songying Li, Shuhong Yi, Binsheng Fu, Yang Yang, Hui Luo. Comparison of in vivo and in vitro split liver transplantation in pediatric liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 688-693.
[10]	Jiachen Zhang, Hongxin Song. The correlation between the changes of spherical equivalent and myopia progression in children with refractive error[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2024, 14(04): 217-222.
[11]	Yongnan Wang, Changtong Tang, Jie Yin, Yitao Tan. Comparative analysis of the efficacy between minimally invasive drilling drainage and neuroendoscopic hematoma removal for the treatment of critical[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2024, 10(05): 286-292.
[12]	Chen Zhang, Ming Qin, Juan Dong, Yulong Chen. Diagnostic value of ultrasound in ischemic changes of intestinal volvulus in children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 565-568.
[13]	Xiaoyu Wang, Qunying Guo, Yameng Niu, Chengsong Zhao. Practice of promoting equal access to pediatric medical care in public children's hospitals[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(04): 383-387.
[14]	Xiaosheng Chen, Jia He, Fang Liu, Rui Wu, Haitao Yang, Xiaohan Fan. Pacemaker implantation in a child with a 31-second cardiac arrest induced by tilt table test: a case report and literature review[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 488-494.
[15]	Yali Cao, Yumeng Gao, Yingqian Zhang, Bo Li, Junbao Du, Hongfang Jin. Clinical progress of sitting intolerance in children[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 510-515.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export